Skip to content
Imvax
  • Contact Us
  • Privacy/Terms
  • Join Our Team
Transforming Cancer OutcomesTM
  • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisors
  • Technology & Proprietary Methodologies
    • Patient Cell Harvest, Treatment, and Implant
    • Immunogenic Cell Death, Patient-Specific Antigens, Innate Immune System Activation
    • Long-term Adaptive Immune Activation and Response
  • Therapeutic Areas
    • Malignant Gliomas
  • Pipeline
    • IGV-001
  • Patients
  • News & Publications
  • Collaboration and Partnerships
Imvax

Contact Us

Imvax > Contact Us
  • Share
    •  
    •  
  • Print

    601 Walnut St, Suite 440 W
    Philadelphia, PA 19106


    tel 267-900-4110

    News

    Stay informed about our latest
    news and developments.

    LEARN MORE

    Patients

    Our patients are the heart of our company, and they, along with their families, friends and caregivers, are just as much members of the Imvax Team.

    LEARN MORE

    601 Walnut St, Suite 440 W
    Philadelphia, PA 19106

    tel 267-900-4110

    • About Us
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Technology & Proprietary Methodologies
    • Patient Cell Harvest, Treatment, and Implant
    • Immunogenic Cell Death, Patient-Specific Antigens, Innate Immune System Activation
    • Long-term Adaptive Immune Activation and Response
    • Pipeline
    • IGV-001
    • Therapeutic Areas
    • Malignant Gliomas
    close ×
    IGV-001
    • Patients
    • News & Publications
    • Collaboration and Partnerships
    • Join Our Team
    Website by Axxiem
    © Copyright Imvax, Inc. All Right Reserved
    Privacy/Terms | Sitemap